Home › Head and Neck Squamous Cell Carcinoma › Virginia › Charlottesville
Head and Neck Squamous Cell Carcinoma clinical trials in Charlottesville, VA
7 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Charlottesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RecruitingPhase 2/3
- Site#0134, Charlottesville
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #66, Charlottesville
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RecruitingPhase 3
- University of Virginia, Charlottesville
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
RecruitingPhase 3
- University of Virginia, Charlottesville
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
RecruitingPhase 1/2
- University of Virginia, Charlottesville
HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma
RecruitingPhase 2
- University of Virginia, Charlottesville
A Study of NX-1607 in Adults With Advanced Malignancies
RecruitingPhase 1
- University of Virginia, Charlottesville
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- Nashville, TN39 studies
- New York City, NY39 studies
- St. Louis, MO28 studies
- Arlington, VA26 studies
- Chicago, IL26 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- Pittsburgh, PA22 studies
- New Haven, CT22 studies
Other studies in Charlottesville
- Non-Small Cell Lung Cancer21 studies
- Acute Myeloid Leukemia16 studies
- Prostate Cancer15 studies
- Metastatic Cancer13 studies
- Endometrial Cancer13 studies
- Cancer (all types)13 studies
- Lung Cancer13 studies
- Heart Failure11 studies
- Ovarian Cancer10 studies
- Colorectal Cancer10 studies
- Type 1 Diabetes9 studies
- Breast Cancer9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.